Low-dose dengue virus 3 human challenge model: a phase 1 open-label study.
Waickman AT, Newell K, Lu JQ, Fang H, Waldran M, Gebo C, Currier JR, Friberg H, Jarman RG, Klick MD, Ware LA, Endy TP, Thomas SJ.
Waickman AT, et al. Among authors: lu jq.
Nat Microbiol. 2024 Apr 1. doi: 10.1038/s41564-024-01668-z. Online ahead of print.
Nat Microbiol. 2024.
PMID: 38561497